1. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study. Issue 10 (October 2022) Authors: de Mooij, C.M.; Samiei, S.; Mitea, C.; Lobbes, M.B.I.; Kooreman, L.F.S.; Heuts, E.M.; Beets-Tan, R.G.H.; van Nijnatten, T.J.A.; Smidt, M.L. Journal: Clinical radiology Issue: Volume 77:Issue 10(2022) Page Start: e732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of axillary disease extent on baseline 18F-FDG PET/CT in clinically node-positive breast cancer patients on the accuracy of axillary surgical staging after NCT. (November 2022) Authors: De Mooij, C.M.; Simons, J.M.; Mitea, C.; van Diest, P.J.; Nelemans, P.J.; Mottaghy, F.M.; van der Pol, C.C.; Luiten, E.J.T.; Koppert, L.B.; Smidt, M.L.; van Nijnatten, T.J.A. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗